Xeris Pharmaceuticals Inc Market Cap ($1.40 Billion)

$1.40 Billion USD · Rank #7274

Market Cap & Net Worth: Xeris Pharmaceuticals Inc (XERS)

Xeris Pharmaceuticals Inc market cap. Xeris Pharmaceuticals Inc (NASDAQ:XERS) has a market capitalization of $1.40 Billion ($1.40 Billion) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #7274 globally and #2239 in its home market, demonstrating a 0.10% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Xeris Pharmaceuticals Inc's stock price $10.46 by its total outstanding shares 182320306 (182.32 Million). Also see Xeris Pharmaceuticals Inc cash flow conversion for how efficiently the company converts equity into cash flow.

Xeris Pharmaceuticals Inc Market Cap History (2018–2026)

Xeris Pharmaceuticals Inc market cap history from 2018 to 2026. Data shows change from $3.10 Billion to $1.91 Billion (-7.57% CAGR). Check Xeris Pharmaceuticals Inc stock price for real-time trading data and today's change.

Index Memberships

Xeris Pharmaceuticals Inc is a constituent of 3 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NASDAQ Health Care IXHC	$2.62 Trillion	0.05%	#214 of 976
NASDAQ Composite IXIC	$40.12 Trillion	0.00%	#817 of 3165
NASDAQ Biotechnology NBI	$1.84 Trillion	0.08%	#127 of 263

Weight: Xeris Pharmaceuticals Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Xeris Pharmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Xeris Pharmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Xeris Pharmaceuticals Inc growing its equity to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

4.90x

Xeris Pharmaceuticals Inc's market cap is 4.90 times its annual revenue

Industry average: 0.59x Higher than industry average

Latest Price to Earnings (P/E) Ratio

2583.42x

Xeris Pharmaceuticals Inc's market cap is 2583.42 times its annual earnings

Industry average: 13.94x Higher than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2018	$3.10 Billion	$2.46 Million	-$60.08 Million	1257.38x	N/A
2019	$1.29 Billion	$2.72 Million	-$125.58 Million	472.21x	N/A
2020	$897.02 Million	$2.72 Million	-$125.58 Million	329.54x	N/A
2021	$534.20 Million	$49.59 Million	-$122.72 Million	10.77x	N/A
2022	$242.49 Million	$110.25 Million	-$94.66 Million	2.20x	N/A
2023	$428.45 Million	$163.91 Million	-$62.26 Million	2.61x	N/A
2024	$618.07 Million	$203.07 Million	-$54.84 Million	3.04x	N/A
2025	$1.43 Billion	$291.85 Million	$554.00K	4.90x	2583.42x

Competitor Companies of XERS by Market Capitalization

Companies near Xeris Pharmaceuticals Inc in the global market cap rankings as of November 5, 2026. Also see Xeris Pharmaceuticals Inc (XERS) total assets for a full breakdown of the balance sheet.

Key companies related to Xeris Pharmaceuticals Inc by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #514 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #538 globally with a market cap of $50.42 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #588 globally with a market cap of $45.79 Billion USD ( CN¥312.89 Billion CNY).
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #621 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#514	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#538	GALDERMA GROUP AG	NYSE:GALDY	$50.42 Billion	$47.80
#588	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$45.79 Billion	CN¥49.05
#621	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€18.50

Market Capitalization of Xeris Pharmaceuticals Inc (2018–2026)

Market capitalization of Xeris Pharmaceuticals Inc from 2018 to today. Between 2018 and today, Xeris Pharmaceuticals Inc's market cap moved from $3.10 Billion to $ 1.91 Billion, with a yearly change of -7.57%.

Year	Market Cap	Change (%)
2026	$1.91 Billion	+33.25%
2025	$1.43 Billion	+131.56%
2024	$618.07 Million	+44.26%
2023	$428.45 Million	+76.69%
2022	$242.49 Million	-54.61%
2021	$534.20 Million	-40.45%
2020	$897.02 Million	-30.21%
2019	$1.29 Billion	-58.53%
2018	$3.10 Billion	--

End of Day Market Cap According to Different Sources

On Nov 5th, 2026 the market cap of Xeris Pharmaceuticals Inc was reported to be:

Source	Market Cap
Yahoo Finance	$1.40 Billion USD
MoneyControl	$1.40 Billion USD
MarketWatch	$1.40 Billion USD
marketcap.company	$1.40 Billion USD
Reuters	$1.40 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Xeris Pharmaceuticals Inc

NASDAQ:XERS USA Drug Manufacturers - Specialty & Generic

Market Cap

$1.91 Billion

Market Cap Rank

#7274 Global

#2239 in USA

Share Price

$10.46

Change (1 day)

+1.06%

52-Week Range

$5.29 - $11.13

All Time High

$27.23